CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Technological advancements propelling market growth
4.1.2. Growth in the aging population and high incidences of chronic illness
4.2. Market Restraints & Challenges
4.2.1. High implementation and maintenance expenses
4.2.2. Reluctance to adopt medication management systems
4.3. Market Opportunities
4.3.1. The rise in focus on value-based medicines
4.3.2. Emerging countries
CHAPTER 5 GLOBAL MEDICATION MANAGEMENT MARKET– BY SYSTEMS
5.1. Introduction
5.2. Computerized Physician Order Entry Systems
5.3. Clinical Decision Support Systems
5.4. Administration Software
5.4.1 Electronic Medication Administration Records (Emar)Software
5.4.2 Bar Code Medication Administration (Bcma) Software
5.5. Inventory Management Systems
5.6. Automated Dispensing Systems
5.6.1. Centralized Automated Dispensing Systems
5.6.1.1. Robots/Robotic Automated Dispensing Systems
5.6.1.2. Carousels
5.6.2. Decentralized Automated Dispensing Systems (Ads)
5.6.2.1. Pharmacy-Based Decentralized Automated Dispensing Systems
5.6.2.2. Ward-Based Decentralized Automated Dispensing Systems
5.6.2.3 Automated Unit-Dose Decentralized Automated Dispensing Systems
5.7. Assurance Systems
CHAPTER 6 GLOBAL MEDICATION MANAGEMENT MARKET– BY SERVICES
6.1. Introduction
6.2. Medication Analytics Services
6.3. Point-Of-Care Verification Services
6.4. Adverse Drug Effects (Ade) Surveillance Services
CHAPTER 7 GLOBAL MEDICATION MANAGEMENT MARKET– BY MODE OF
DELIVERY
7.1. Introduction
7.2. Web-Based Solutions
7.3. On-Premise Solutions
7.4. Cloud-Based Solutions
CHAPTER 8 GLOBAL MEDICATION MANAGEMENT MARKET– BY END USER
8.1. Introduction
8.2. Hospitals
8.3. Pharmacies
8.4. Other Healthcare Institutions
CHAPTER 9 GLOBAL MEDICATION MANAGEMENT MARKET- BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL MEDICATION MANAGEMENT MARKET- COMPANY
PROFILES
10.1. Siemens Healthcare
10.2. CareFusion Corporation
10.3. Ge Healthcare
10.4. Allscripts Healthcare Solutions, Inc.
10.5. Mckesson Corporation
10.6. Cerner Corporation
10.7. Optum Inc.
10.8. Meditech
10.9. Omnicell, Inc.
10.10. Quadramed Corporation
10.11. B. Braun Melsungen
10.12. Baxter International, Inc.,
10.13. Hospira, Inc.
10.14. McKesson Corporation
10.15. Koninklijke Philips N.V.
CHAPTER 11 GLOBAL MEDICATION MANAGEMENT MARKET- COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
